Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tirzepatide
Marketing
Rybelsus brand retired in US as ‘Ozempic pill’ takes the stage
The semaglutide franchise is changing up its branding as Novo Nordisk is retiring the Rybelsus name in favor of its better-known brand.
Ben Adams
,
Fraiser Kansteiner
May 1, 2026 8:00am
Lilly warns of 'impurity' in some compounded tirzepatide drugs
Mar 12, 2026 10:00am
FDA unleashes warning letters to firms selling compounded GLP-1s
Mar 4, 2026 8:30am
Fierce Biotech
How GLP-1s help the heart relax: study
Mar 2, 2026 7:01pm
Lilly touts Zepbound-Taltz combo in patients with obesity, PsA
Jan 8, 2026 2:00pm
Lilly, Novo reach GLP-1 pricing deals with White House
Nov 6, 2025 12:26pm